<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/cellectis-cut-up-to-70-percent-staff-drops-car-t-trials</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:01:46.516Z</news:publication_date>
      <news:title>Cellectis to Cut Up to 70% of Staff After Dropping Its CAR-T Trials</news:title>
      <news:keywords>Cellectis, layoffs, CAR-T, gene editing, cell therapy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-turns-down-summit-ivonescimab-lung-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:59:35.417Z</news:publication_date>
      <news:title>FDA Turns Down Summit Lung Cancer Drug Tied to $2B AstraZeneca Deal</news:title>
      <news:keywords>Summit Therapeutics, ivonescimab, FDA, lung cancer, complete response letter</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/lilly-3-5b-pennsylvania-obesity-drug-site-850-jobs</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T14:01:10.299Z</news:publication_date>
      <news:title>Lilly&apos;s $3.5B Pennsylvania Obesity Drug Site to Create 850 Jobs</news:title>
      <news:keywords>Eli Lilly, manufacturing, Pennsylvania, obesity, jobs</news:keywords>
    </news:news>
  </url>
</urlset>